Trademark Details For WILPAXA (Serial Number 97648335)

  •  Home
  •  Print
WILPAXA
1
3
2
0
Basic Information
Serial Number  United States - USPTO 97648335
Registration Number -
Mark
WILPAXA
Filing Date Oct-26-2022
Status
Dead  
ABANDONED - .. (606)
ABANDONED - NO STATEMENT OF USE FILED
Attorney Name
TTAB
0


  • TEVA PHARMACEUTICALS USA


005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active





Correspondences

NameLaurence Rickles TEVA PHARMACEUTICALS USA, INC.
Address400 INTERPACE PARKWAY BUILDING A PARSIPPANY, NJ 07054 United States

Prosecution History

USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Oct-29-2022NEW APPLICATION ENTERED   NWAPI
Oct-31-2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Aug-01-2023ASSIGNED TO EXAMINER   DOCKD
Aug-08-2023APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Aug-23-2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Sep-12-2023PUBLISHED FOR OPPOSITION   PUBOA
Sep-12-2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Oct-05-2023EXTENSION OF TIME TO OPPOSE RECEIVED   ETOFT
Jan-21-2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED   ETOPT
Apr-09-2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Sep-25-2024SOU TEAS EXTENSION RECEIVED   EEXTI
Sep-25-2024SOU EXTENSION 1 FILED   EXT1S
Sep-25-2024SOU EXTENSION 1 GRANTED   EX1GS
Sep-25-2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Mar-13-2025SOU TEAS EXTENSION RECEIVED   EEXTI
Mar-13-2025SOU EXTENSION 2 FILED   EXT2S
Mar-14-2025SOU EXTENSION 2 GRANTED   EX2GS
Mar-14-2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Nov-10-2025ABANDONMENT - NO USE STATEMENT FILED   ABN6S
Nov-10-2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED   MAB6E